Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort.
Tuan Le VanThomas GraillonJulian JacobElodie VauleonLoic FeuvretAnne-Laure BochJulien BoettoMathieu BooneCharlotte BronnimannFrançois CaireAmaury De BarrosMariette DelaitreAnna Luisa Di StefanoMélanie DoreFrançois DucrayChristelle DufourJulien EngelhardtDenys FontaineSebastien FroelichMatthieu HelleringerAymeri HuchetAnthony JoncourEmmanuel JouanneauCharles-Henry MallereauApolline MonfillietteEmmanuelle Le FurIlyess ZemmouraOlivier ChinotMarc SansonMichel KalamaridesHugues LoiseauMatthieu PeyrePublished in: Journal of neuro-oncology (2021)
Surgery- and radiation-refractory meningiomas represent a heterogeneous group of tumors with a majority of WHO Grade II cases. If re-irradiation and redo-surgery are not possible, bevacizumab and octreotide-everolimus appear as a valuable option in heavily pre-treated patients considering the current EANO guidelines.